Literature DB >> 14999009

Properties of two distinct heme centers of cytochrome b561 from bovine chromaffin vesicles studied by EPR, resonance Raman, and ascorbate reduction assay.

Fusako Takeuchi1, Hiroshi Hori, Eiji Obayashi, Yoshitsugu Shiro, Motonari Tsubaki.   

Abstract

Cytochrome b(561) from bovine adrenal chromaffin vesicles contains two hemes b with different midpoint potentials (+150 and +60 mV) and participates in transmembrane electron transport from extravesicular ascorbate to an intravesicular monooxygenase, dopamine beta-hydroxylase. Treatment of oxidized cytochrome b(561) with diethylpyrocarbonate caused a downshift of midpoint potential for the lower component, and this shift was prevented by the presence of ascorbate during the treatment. Present EPR analyses showed that, upon the treatment, the g(z) = 3.69 heme species was converted to a non-ascorbate-reducible form, although its g(z)-value showed no appreciable change. The treatment had no effect on the other heme (the g(z) = 3.13 species). Raman data indicated that the two heme b centers adopt a six-coordinated low-spin state, in both the reduced and oxidized forms. There was no significant effect of diethylpyrocarbonate-treatment on the Raman spectra of either form, but the reducibility by ascorbate differed significantly between the two hemes upon the treatment. The addition of ferrocyanide enhanced both the reduction rate and final reduction level of the diethylpyrocarbonate-treated cytochrome b(561) when ascorbate was used as a reductant. This observation suggests that ferrocyanide scavenges monodehydroascorbate radicals produced by the univalent oxidation of ascorbate and, thereby, increases both the reduction rate and the final reduction level of the heme center on the intravesicular side of the diethylpyrocarbonate-treated cytochrome. These results further clarify the physiological role of this heme center as the electron donor to the monodehydroascorbate radical.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999009     DOI: 10.1093/jb/mvh006

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Functional and structural roles of residues in the third extramembrane segment of adrenal cytochrome b561.

Authors:  Wen Liu; Giordano F Z da Silva; Gang Wu; Graham Palmer; Ah-Lim Tsai; Richard J Kulmacz
Journal:  Biochemistry       Date:  2011-03-25       Impact factor: 3.162

Review 2.  Cytochromes b561: ascorbate-mediated trans-membrane electron transport.

Authors:  Han Asard; Raffaella Barbaro; Paolo Trost; Alajos Bérczi
Journal:  Antioxid Redox Signal       Date:  2013-02-04       Impact factor: 8.401

3.  Spectral characterization of the recombinant mouse tumor suppressor 101F6 protein.

Authors:  Alajos Bérczi; Filip Desmet; Sabine Van Doorslaer; Han Asard
Journal:  Eur Biophys J       Date:  2009-11-27       Impact factor: 1.733

4.  Systems and trans-system level analysis identifies conserved iron deficiency responses in the plant lineage.

Authors:  Eugen I Urzica; David Casero; Hiroaki Yamasaki; Scott I Hsieh; Lital N Adler; Steven J Karpowicz; Crysten E Blaby-Haas; Steven G Clarke; Joseph A Loo; Matteo Pellegrini; Sabeeha S Merchant
Journal:  Plant Cell       Date:  2012-10-05       Impact factor: 11.277

5.  His92 and His110 selectively affect different heme centers of adrenal cytochrome b(561).

Authors:  Wen Liu; Corina E Rogge; Giordano F Z da Silva; Vladimir P Shinkarev; Ah-Lim Tsai; Yury Kamensky; Graham Palmer; Richard J Kulmacz
Journal:  Biochim Biophys Acta       Date:  2008-05-01

6.  Heme binding properties of glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Luciana Hannibal; Daniel Collins; Julie Brassard; Ritu Chakravarti; Rajesh Vempati; Pierre Dorlet; Jérôme Santolini; John H Dawson; Dennis J Stuehr
Journal:  Biochemistry       Date:  2012-10-15       Impact factor: 3.162

Review 7.  Ferric iron reductases and their contribution to unicellular ferrous iron uptake.

Authors:  Timothy J Cain; Aaron T Smith
Journal:  J Inorg Biochem       Date:  2021-02-25       Impact factor: 4.155

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.